EU GMP Annex 1, Section 7 - Production and Specific Technologies

What it says

Specific manufacturing technologies used in sterile product production, including aseptic processing, terminal sterilization, lyophilization and blow-fill-seal, carry additional technology-specific contamination control expectations that must be addressed within the site's overall Contamination Control Strategy.

Paraphrased for plain-language clarity. Always verify against the current published regulation text.

What it means in practice

• Each manufacturing technology named in this section carries its own distinct contamination risk profile, meaning a Contamination Control Strategy written generically without addressing the specific technology in use is unlikely to meet this section's expectations.
• Lyophilization, for example, introduces contamination risk during loading, unloading and the vacuum drying process itself, risks that simply do not arise in a conventional aseptic filling operation.
• Blow-fill-seal technology integrates container formation and filling into a single continuous process, which changes where and how contamination control and environmental monitoring need to be applied compared with conventional vial filling.

What inspectors look for

• Whether the Contamination Control Strategy specifically addresses the actual manufacturing technology in use, rather than applying generic aseptic processing language regardless of the technology.
• Whether technology-specific risks, such as lyophilizer loading and unloading or blow-fill-seal container formation, have documented controls and monitoring tailored to that risk.
• Whether personnel training addresses the specific technology's unique contamination risks, not just general aseptic technique.

Related regulations